Fly News Breaks for March 6, 2015
OREX
Mar 6, 2015 | 11:40 EDT
RBC Capital said weakness in Orexigen is a buying opportunity and expects shares to eventually rebound on expectations of EU approval in late March, partnership announcements, and continuation of strong U.S. launch by Takeda salesforce. Shares are Overweight rated.
News For OREX From the Last 2 Days
There are no results for your query OREX